222 companies

TG Therapeutics

Market Cap: US$5.7b

A commercial stage biopharmaceutical company, focuses on the acquisition, development, and commercialization of novel treatments for B-cell mediated diseases in the United States and internationally.

TGTX

US$37.91

7D

2.2%

1Y

80.5%

Alnylam Pharmaceuticals

Market Cap: US$42.3b

Alnylam Pharmaceuticals, Inc. discovers, develops, and commercializes therapeutics based on ribonucleic acid interference.

ALNY

US$320.53

7D

1.8%

1Y

34.8%

Circle Internet Group

Market Cap: US$53.5b

Operates as a platform, network, and market infrastructure for stablecoin and blockchain applications.

CRCL

US$223.78

7D

19.5%

1Y

n/a

Ascendis Pharma

Market Cap: US$10.7b

Operates as a biopharmaceutical company that focuses on developing TransCon-based therapies for unmet medical needs in Denmark, rest of Europe, North America, and internationally.

ASND

US$169.90

7D

-2.9%

1Y

25.7%

Alkami Technology

Market Cap: US$2.9b

Provides cloud-based digital banking solutions in the United States.

ALKT

US$27.81

7D

-3.0%

1Y

-14.9%

AVITA Medical

Market Cap: US$144.2m

Operates as a therapeutic acute wound care company in the United States, Japan, the European Union, Australia, and the United Kingdom.

RCEL

US$5.17

7D

-9.3%

1Y

-46.5%

Lumentum Holdings

Market Cap: US$7.1b

Manufactures and sells optical and photonic products in the Americas, the Asia-Pacific, Europe, the Middle East, and Africa.

LITE

US$102.22

7D

9.9%

1Y

86.6%

Caris Life Sciences

Market Cap: US$8.7b

An artificial intelligence TechBio company, provides molecular profiling services in the United States and internationally.

New

CAI

US$30.19

7D

13.9%

1Y

n/a

Ardelyx

Market Cap: US$1.1b

Ardelyx, Inc. discovers, develops, and commercializes medicines to treat unmet medical needs in the United States and internationally.

ARDX

US$4.52

7D

-3.8%

1Y

-17.7%

Super Micro Computer

Market Cap: US$31.5b

Develops and sells high performance server and storage solutions based on modular and open architecture in the United States, Europe, Asia, and internationally.

SMCI

US$51.77

7D

5.1%

1Y

-35.0%

Mereo BioPharma Group

Market Cap: US$283.0m

A biopharmaceutical company, develops and commercializes therapeutics for the treatment of oncology and rare diseases in the United Kingdom, the United States, and internationally.

MREO

US$1.77

7D

9.9%

1Y

-54.4%

Blueprint Medicines

Market Cap: US$8.4b

A precision therapy company, develops medicines for genomically defined cancers and blood disorders in the United States and internationally.

BPMC

US$129.46

7D

0.1%

1Y

14.1%

Palantir Technologies

Market Cap: US$363.4b

Palantir Technologies Inc. builds and deploys software platforms for the intelligence community to assist in counterterrorism investigations and operations in the United States, the United Kingdom, and internationally.

PLTR

US$153.52

7D

8.0%

1Y

437.2%

Alvotech

Market Cap: US$2.7b

Through its subsidiaries, develops and manufactures biosimilar medicines for patients worldwide.

ALVO

US$8.63

7D

1.3%

1Y

-27.7%

Legend Biotech

Market Cap: US$7.8b

Through its subsidiaries, operates as a biopharmaceutical company that discovers, develops, manufactures, and commercializes novel cell therapies for oncology and other indications in the United States, China, and Europe.

LEGN

US$41.59

7D

6.8%

1Y

-29.2%

UroGen Pharma

Market Cap: US$661.2m

Engages in the development and commercialization of solutions for urothelial and specialty cancers.

URGN

US$15.41

7D

5.3%

1Y

-7.4%

Travere Therapeutics

Market Cap: US$1.5b

A biopharmaceutical company, identifies, develops, and delivers therapies to people living with rare kidney and metabolic diseases in the United States.

TVTX

US$16.51

7D

-0.2%

1Y

68.3%

Roadzen

Market Cap: US$77.3m

Operates an Insurtech company in India, the United States, the United Kingdom, and Europe.

RDZN

US$1.05

7D

1.0%

1Y

-48.5%

Vanda Pharmaceuticals

Market Cap: US$283.5m

A biopharmaceutical company, focuses on the development and commercialization of therapies to address high unmet medical needs worldwide.

VNDA

US$4.86

7D

-2.6%

1Y

-19.9%

Workday

Market Cap: US$61.6b

Provides enterprise cloud applications in the United States and internationally.

WDAY

US$233.06

7D

4.3%

1Y

2.4%

TeraWulf

Market Cap: US$2.1b

Operates as a digital asset technology company in the United States.

WULF

US$5.13

7D

4.9%

1Y

-8.2%

Abeona Therapeutics

Market Cap: US$339.2m

A clinical-stage biopharmaceutical company, develops gene and cell therapies for life-threatening diseases.

ABEO

US$6.59

7D

14.8%

1Y

29.0%

TruGolf Holdings

Market Cap: US$63.2m

Through its subsidiary, engages in the design, development, manufacture, and sale of golf simulators for residential and commercial applications in the United States.

TRUG

US$5.71

7D

11.4%

1Y

-89.5%

RenovoRx

Market Cap: US$47.5m

A clinical-stage biopharmaceutical company, engages in the developing of targeted combination therapies to enhance therapeutic outcomes for cancer patients undergoing treatment.

RNXT

US$1.30

7D

1.2%

1Y

12.1%

Gorilla Technology Group

Market Cap: US$578.0m

Provides solutions in security, network, business intelligence, and Internet of Things (IoT) technology in Taiwan and the United Kingdom.

GRRR

US$19.04

7D

-5.9%

1Y

580.0%

OS Therapies

Market Cap: US$49.8m

A clinical stage biopharmaceutical company, focuses on the identification, development, and commercialization of treatments for osteosarcoma and other solid tumors in the United States.

OSTX

US$1.64

7D

-3.5%

1Y

n/a

Aldeyra Therapeutics

Market Cap: US$301.3m

A biotechnology company, discovers and develops therapies designed to treat immune-mediated and metabolic diseases.

ALDX

US$5.39

7D

15.9%

1Y

41.1%

Nutanix

Market Cap: US$20.1b

Provides an enterprise cloud platform in North America, Europe, the Asia Pacific, the Middle East, Latin America, and Africa.

NTNX

US$75.55

7D

4.4%

1Y

56.4%

ACADIA Pharmaceuticals

Market Cap: US$3.8b

A biopharmaceutical company, focuses on the development and commercialization of medicines for central nervous system (CNS) disorders and rare diseases in the United States.

ACAD

US$22.56

7D

7.5%

1Y

27.1%

Zscaler

Market Cap: US$44.6b

Operates as a cloud security company worldwide.

ZS

US$288.72

7D

-0.4%

1Y

53.1%

Similarweb

Market Cap: US$698.4m

Provides digital data and analytics for power critical business decisions in the United States, Europe, the Asia Pacific, the United Kingdom, Israel, and internationally.

SMWB

US$8.57

7D

3.5%

1Y

24.2%

Soleno Therapeutics

Market Cap: US$4.6b

A clinical-stage biopharmaceutical company, focuses on the development and commercialization of novel therapeutics for the treatment of rare diseases.

SLNO

US$87.20

7D

6.9%

1Y

85.7%

Capricor Therapeutics

Market Cap: US$327.3m

A clinical-stage biotechnology company, engages in the development of transformative cell and exosome-based therapeutics for treating duchenne muscular dystrophy (DMD) and other diseases with unmet medical needs in the United States.

CAPR

US$6.88

7D

-9.9%

1Y

46.7%

Achieve Life Sciences

Market Cap: US$136.6m

A late-stage pharmaceutical company, develops and commercializes cytisinicline for nicotine independence in Canada, the United States, and the United Kingdom.

ACHV

US$2.68

7D

15.5%

1Y

-42.1%

Spotify Technology

Market Cap: US$147.8b

Provides audio streaming subscription services worldwide.

SPOT

US$695.48

7D

-1.9%

1Y

135.7%

Pagaya Technologies

Market Cap: US$2.2b

A product-focused technology company, deploys data science and proprietary artificial intelligence-powered technology for financial services and other service providers, their customers, and asset investors in the United States, Israel, and the Cayman Islands.

PGY

US$31.12

7D

35.2%

1Y

112.3%

Page 1 of 7